CEimpact

I've a Feeling Dapagliflozin Isn't in Kansas Anymore

Overview / Abstract:	Should you use a diabetes medication in a patient without diabetes? A recent NEJM publication supports the use of SGLT2 inhibitors in patients with heart failure but without a diabetes diagnosis. Join October's Journal Club, lead by Dr. Raven Jackson, PharmD to learn how a historically 'diabetes drug' may now benefit a new patient population.
Expiration	Oct 14, 2023
Discipline(s)	Pharmacy CPE
Format	Online, Webinar / Webcast / Video
Cost	9.00
Credits / Hours	0.10
Accreditation	ACPE
Presenters / Authors / Faculty	Raven Jackson, PharmD Clinical Assistant Professor Division of Clinical and Administrative Sciences College of Pharmacy Xavier University of Louisiana
Keywords / Search Terms	CEimpact CEI Impact CEI ce, diabetes, heart failure, journal club, trial, clinical trial, journal, sglt-2is, american diabetes association

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map